Introduction
============

The normal physiologic status of redox homeostasis consists of a balance between produced and scavenged reactive oxygen species (ROS). ROS and antioxidants are known to affect the expression of numerous genes and multiple signaling pathways. In fact, a variety of tumor cells constitutively produce large quantities of hydrogen peroxide (H~2~O~2~) compared to normal cells [@B1]. Large quantities of ROS including the superoxide, H~2~O~2~, and the hydroxyl radical, surround the tumor microenvironment and play an essential role in tumor progression [@B2]-[@B3]. Among the ROS, H~2~O~2~ acts as a second messenger for the expression of various genes, including those closely involved in tumor proliferation, angiogenesis, and metastasis [@B4]-[@B6].

The smallest matrix metalloproteinase (MMP), MMP-7 (matrilysin), is secreted in a 28-kDa latent form and is then activated through proteolytic removal of a 9-kDa prodomain from the N-terminus to the 19-kDa active form [@B7]. The expression of MMP-7 correlated significantly with the presence of distant metastases in colorectal cancers (CRCs) and could be a predictive marker for patients after surgical treatment or radiotherapy [@B8]-[@B11]. However, radiation exposure of tumor cells can also affect the neighboring bystander cells associated with H~2~O~2~ generation [@B12]-[@B13]. Exogenous H~2~O~2~ has been shown to be an important mediator in the induction of several genes from distinct signal transduction pathways [@B2], [@B5], [@B14]-[@B15]. H~2~O~2~-induced MMP-7 expression via JNK/AP-1 pathway activation has also been recently observed in cultured cells [@B16].

The hydroxamic acid derivative of dimerumic acid (DMA) isolated from *Monascus*-fermented rice has been conclusively proven to have radical scavenging activity [@B17]-[@B18]. *Monascus*-fermented products are widely used for the preparation of fermented foods and are utilized as traditional Chinese medicine for the anti-cholesterol effects [@B19]. In the present study, we showed that DMA was critical for H~2~O~2~-mediated upregulation of MMP-7 and cell invasion in an SW620 human colon cancer cell line that was established from a lymph node metastasis of a CRC patient [@B20]. Moreover, DMA could effectively prevent cancer cell invasion by suppressing H~2~O~2~-stimulated MMP-7 gene transcription via complex AP-1-dependent mechanisms, which required the upstream signal transduction from both the JNK/c-Jun and the ERK/c-Fos signaling pathways. These results indicated for the first time a potential chemopreventive role for DMA in other aspects of CRC metastasis.

Materials and methods
=====================

Experimental reagents
---------------------

DMA (C~22~H~37~N~4~O~8~) was isolated from *Monascus purpureus* NTU 568-fermented rice. Fetal bovine serum (FBS) and TRIzol were purchased from Invitrogen (Carlsbad, CA, USA). Leibovitz\'s L-15 medium, 0.05% trypsin-EDTA, and 1× antibiotic-antimycotic were obtained from Hyclone (Logan, UT, USA). Phosphorylated JNK1/2, ERK1/2, and p38 MAPK and nonphosphorylated JNK1/2, ERK1/2, and p38 antibodies and anti-β-actin were purchased from Cell Signaling Technology, Inc. (Beverly, MA, USA). MMP-7, c-Fos, c-Jun, and the anti-mouse IgG horseradish peroxidase (HRP)-linked and anti-rabbit IgG HRP-linked secondary antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). MMP-7 neutralizing antibody (MAB3322) was purchased from Millipore (Chemicon, Temecula, CA, USA). The MAPK inhibitors SP600125 (JNK1/2 inhibitor), PD98059 (ERK1/2 inhibitor), and SB202190 (p38 inhibitor) were purchased from Calbiochem (San Diego, CA, USA). All other chemicals employed in this study were of analytical grade and were purchased from Sigma Chemical Co. (St. Louis, MO, USA).

Cell culture and viability assay
--------------------------------

The human colorectal adenocarcinoma cell line SW620 was purchased from the Bioresource Collection and Research Center in Taiwan. Cells were cultured in Leibovitz\'s L-15 medium with 10% FBS and 1× antibiotic-antimycotic (HyClone), and incubated at 37°C in an atmosphere devoid of CO~2~. To measure cell survival after exposure to DMA and H~2~O~2~, MTT assays were carried out on these 2 groups. SW620 cells were incubated in 24-well plates in 1 mL of L-15 medium. Experimental details including concentrations and test incubation times are described in the text and the corresponding figure legend. Incubation was terminated by media aspiration and addition of 5 mg/mL of MTT working solution to each well. Formazane formation was terminated after 3 h by removal of the MTT solution. Subsequently, appropriate amounts of DMSO were added to each well to solubilize the formazane. The formazane-containing samples were transferred to a new 96-well plate and measured at 590 nm by an Opsys MR microplate spectrophotometer (Thermo LabSystems, Chantilly, VA, USA).

Matrigel invasion assay
-----------------------

Matrigel-coated transwell chambers with Millicell-HA filters (8-µm pore size; Millipore Co., Bedford, MA, USA) were used to assess the role of DMA and H~2~O~2~ on the invasive potential of SW620 cells. The frozen Matrigel was thawed overnight in a 4°C refrigerator and maintained on ice before use. The liquefied Matrigel was diluted in serum-free L-15 medium to a final concentration of 50 µg/mL, aliquoted into the inner chambers, and gelated at 37°C. The lower chambers contained medium with 10% FBS, and the upper chambers contained cells that were pretreated with DMA, H~2~O~2~, or a combination. Cells were incubated at 37°C for 24 h in the absence of CO~2~. Non-invading cells in the upper chamber were then wiped off with a cotton swab. Cells that had attached to the lower surface of the membrane were fixed with 4% formaldehyde, stained with 0.5% crystal violet, and counted microscopically. Microscopic fields were photographed with a digital camera and each photograph was measured using NIH ImageJ software (<http://rsb.info.nih.gov/ij/>). Three separate microscopic fields on the stained membranes from duplicate experiments were counted to determine the average number of cells/field (error bar = SD), and differences were considered significant at p \< 0.05.

RNA isolation and reverse-transcription PCR analysis
----------------------------------------------------

Total RNA was extracted from cells using TRIzol (Invitrogen) according to the manufacturer\'s protocol. The concentrations of purified RNA were measured spectrophotometrically using a Picodrop (Picodrop Ltd., Walden, UK). The reverse transcription (RT) reaction was performed using a SuperScript III First-Strand Synthesis System (Invitrogen) according to the manufacturer\'s protocol. Amplification of the RT product by PCR was performed using Promega Taq DNA Polymerase (Promega Co., Madison, WI, USA). All reactions were performed in a thermal cycler (model 2400; Perkin-Elmer, Norwalk, CT, USA) with the following primers: MMP-7 sense, 5\'- GGT CAC CTA CAG GAT CGT ATC ATA T-3\', MMP-7 antisense, 5\'-CAT CAC TGC ATT AGG ATC AGA GGA A-3\', glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sense, 5\'-TGA TGA CAT CAA GAA GGT GGT GAA G-3\', and GAPDH antisense, 5\'-TCC TTG GAG GCC ATG TGG GCC AT-3\'. The reaction sequence consisted of 1 cycle of initial denaturation at 94°C for 5 min, 30 cycles of denaturation at 94°C for 1 min, primer annealing at 62°C for 1 min, extension at 72°C for 1 min, and then 1 cycle of final extension at 72°C for 5 min. The PCR products of MMP-7 (373 bp) and GAPDH (240 bp) were run on 1.5% agarose gel, and then stained with ethidium bromide. The stained bands were visualized using UVP GDS-7900 digital imaging system (UVP AutoChemi System, Cambridge, UK).

Preparation of cell extracts and Western blot analysis
------------------------------------------------------

Cells were cultivated and treated as described in the text. The cells were washed twice with ice-cold PBS followed by the addition of 1 mL of radioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich) with protease inhibitors. The cells were rapidly scraped off, and the crude lysates were transferred to microtubes and centrifuged at 15,000 × *g* for 30 min at 4°C. Cleared cell lysates containing equal amounts of proteins (50 µg) were denatured in sample buffer and separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidene difluoride membranes (PVDF; Pall Corporation, Ann Arbor, MI, USA). After blocking with 5% non-fat dry milk in PBS with 0.05% Tween 20 (PBST), the PVDF membranes were incubated overnight at 4°C with the chosen primary antibodies and then probed with the appropriate HRP-conjugated secondary antibodies to visualize specific bands using a Western Lightning Chemiluminescence Reagent kit (PerkinElmer, Waltham, MA, USA).

Casein zymography
-----------------

Total proteins were loaded on precast 12% Novex zymogram blue casein gels (Invitrogen) to measure MMP-7 proteolytic activity. Following electrophoresis, the gels were renatured in Novex Zymogram Renaturing Buffer (Invitrogen) for 30 min at room temperature and then incubated at 37°C in Novex Zymogram Developing Buffer (Invitrogen) to allow degradation of the substrate in the gel matrix. Enzymatic activity was visualized as a clear band against a dark background.

Transient transfection and luciferase activity assay
----------------------------------------------------

Transient transfections were performed using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer\'s protocol. SW620 cells cultured in 6-well plates at a density of 5 × 10^5^ cells/well were cotransfected with 1 µg of pAP1-luc and 0.05 µg of control pRL-TK reference vector (Promega). Cells were incubated with transfection reagent for 6 h and then changed with growth medium to recover for 24 h. After preincubation with SP600125, SB203580, PD98059, or DMA for 30 min, cells were treated with H~2~O~2~ in the presence or absence of MAPK inhibitors for 24 h. For the luciferase reporter assays, cells were harvested in 200 μL of Passive Lysis Buffer (PLB) and quantitation of relative light units was determined using a Dual Luciferase Stop & Glo reagent kit according the manufacturer\'s protocol (Promega).

Statistical analysis
--------------------

Data are expressed as means ± standard deviation. Differences/correlations between groups were calculated using Student\'s *t*-test. Statistical significance was determined at p \< 0.05.

Result
======

High dose concentration administration of H~2~O~2~ but not DMA inhibits SW620 cell viability
--------------------------------------------------------------------------------------------

The *Monascus* secondary metabolite DMA (Fig. [1](#F1){ref-type="fig"}A) is a known antioxidant compound in *Monascus*-fermented products [@B21]. However, the potential anticancer activity of DMA is completely unknown. In this study, we first evaluated the general cytotoxicity of DMA on SW620 colon cancer cells.

To examine DMA toxicity, SW620 cells were treated with DMA (10-200 μM) and incubated for 24 h. The percentage of viable cells was determined using an MTT assay and compared with control cells (vehicle). In our results, DMA concentration up to 200 μM did not influence cell viability. Nevertheless, high H~2~O~2~ accumulation (10-200 μM) resulted in poor viability in a dose-dependent manner (Fig. [1](#F1){ref-type="fig"}B). Cells were subsequently treated with 100 µM DMA or 10 µM H~2~O~2~ for the times indicated (24-72 h) to evaluate the duration effects. Time-dependent inhibition of SW620 cell viabilities were observed only under H~2~O~2~ treatment and not by DMA addition (Fig.[1](#F1){ref-type="fig"}C).

DMA prevents H~2~O~2~-induced SW620 colon cancer cell invasion
--------------------------------------------------------------

Because the preliminary result indicated that accumulation of 5 μM H~2~O~2~ had no lethal effect on SW620 cells, cell invasion assessment was done at 0.1, 1, and 5 μM of H~2~O~2~ treatment. The effect of H~2~O~2~ on the invasive activity of metastatic SW620 cells was measured using a Matrigel-coated Boyden chamber invasion assay. Representative images of filters containing invaded cells were taken with a microscope using a 10× objective lens and reveal that H~2~O~2~ dramatically increased invading cell numbers in a dose-dependent manner (Fig. [2](#F2){ref-type="fig"}A). To investigate whether H~2~O~2~-mediated cell invasion could be antagonized by DMA, SW620 cells were pretreated with DMA (100 μM) for 30 min and then incubated with non-toxic dose of H~2~O~2~ (5 μM) for 24 h. Results showed that 100 μM of DMA effectively disrupted Matrigel invasion in the presence of H~2~O~2~ (Fig. [2](#F2){ref-type="fig"}B). To confirm the role of MMP-7 in H~2~O~2~-modulated cell invasion, we further treated SW620 cells with MMP-7 neutralizing antibody (10 μg/mL) or control IgG. After 24 h, the invasive ability of SW620 cells was significantly decreased after MMP-7 neutralizing antibody treatment (Fig. [2](#F2){ref-type="fig"}C). These results indicate that DMA prevents H~2~O~2~-induced cell invasion and that MMP-7 activity may play an important role in the management of cancer invasion.

DMA suppresses H~2~O~2~-facilitated MMP-7 expression
----------------------------------------------------

We investigated the role of MMP-7, which is believed to play an important part in the invasion process [@B22] and was found to be activated in a clinical study [@B11]. Using semi-quantitative RT-PCR analysis, we found that the mRNA expression of MMP-7 in SW620 cells was up-regulated by H~2~O~2~ induction in a time-dependent increase and that it peaked at 4 h. MMP-7 mRNA transcription was not induced by DMA (100 μM), but by TPA (0.1 μM), in SW620 cells which were continuously incubated for 8 h (Fig. [3](#F3){ref-type="fig"}A). This finding suggests that DMA is unlikely to directly inhibit MMP-7 activity. Furthermore, SW620 cells were treated with H~2~O~2~ at the indicated doses for 4 h. MMP-7 mRNA expression increased in a dose-dependent manner after H~2~O~2~ treatment, but decreased after DMA pretreatment (Fig. [3](#F3){ref-type="fig"}B). Western blot analyses showed that H~2~O~2~ induced MMP-7 protein expression in a time-dependent manner (Fig. [3](#F3){ref-type="fig"}C). Finally, casein zymographic analysis showed that caseinolytic activities were upregulated by H~2~O~2~ (5 μM) treatment and suppressed by DMA pretreatment (Fig. [3](#F3){ref-type="fig"}D). All of the obtained bands were quantitated by densitometry using the ImageJ program (NIH). The data are representative of three separate experiments that yielded similar results.

Inhibitory effects of DMA on H~2~O~2~-induced MAPK activation
-------------------------------------------------------------

To address the question of what kind of signaling might be involved in MMP-7 induction by H~2~O~2~ and negative DMA regulation, we analyzed the effects of inhibiting protein kinases that have been shown to participate in free radical stress signaling [@B23]. When the tumor microenvironment is insufficient for redox homeostasis, the ROS level, including H~2~O~2~ in tumors, becomes elevated compared to that in surrounding normal tissues. Cancer cells encountering high ROS levels are known to activate MAPK pathways such as ERK1/2, p38 MAPK, and JNK [@B6]. We examined the role of DMA and the influence of these MAPK pathways on H~2~O~2~-mediated activation of MMP-7 activity. Using Western blotting analyses, we observed marked activation of p-JNK1/2 (Fig. [4](#F4){ref-type="fig"}A), p-ERK1/2 (Fig. [4](#F4){ref-type="fig"}B), and p-p38 MAPK (Fig. [4](#F4){ref-type="fig"}C) within 1 h after H~2~O~2~ (5 μM) treatment in SW620 cells. Interestingly, DMA treatment alone failed to affect JNK1/2, ERK1/2, or p38 MAPK phosphorylation, but DMA pretreatment could effectively suppress H~2~O~2~-induced MAPKs activation. In addition, MMP-7 protein was expressed soon after H~2~O~2~ stimulation, resulting in an 8-fold increase in MMP-7 protein levels over the control (Fig. [4](#F4){ref-type="fig"}D). Specific MAPK inhibitors were used to determine which MAPK pathway activation mediates H~2~O~2~-induced MMP-7 activities. Pretreatment with SP600125 (50 μM) or PD98059 (50 μM), the specific JNK1/2 and ERK1/2 inhibitors, respectively, significantly reduced MMP-7 protein expression to near basal control levels. In contrast, inhibition of H~2~O~2~-stimulated p38 MAPK activation by SB203580 (10 μM) only slightly decreased MMP-7 protein levels (no significant difference) (Fig. [4](#F4){ref-type="fig"}D). These results indicate a critical role of both JNK1/2 and ERK1/2, but not p38 MAPK, in H~2~O~2~-induced MMP-7 expression in SW620 cells.

DMA suppresses H~2~O~2~-induced MMP-7 expression by inhibiting AP-1 mediated gene expression via the JNK/c-Jun and ERK/c-Fos signaling pathway in SW620 cells
-------------------------------------------------------------------------------------------------------------------------------------------------------------

The results described above indicated that both JNK and ERK phosphorylation are potent stimulators of MMP-7 expression and cell invasion. In addition, the MMP-7 promoter has been shown to contain an AP-1 motif between positions -67 to -61 [@B24] that is recognized by the transcription factors and is composed of members of the c-Jun and c-Fos families [@B25]. To address the signaling cascades by which H~2~O~2~ stimulates MAPK activation, we next examined the effect of H~2~O~2~ on the transactivating function of c-Jun and c-Fos of the AP-1 family of transcription factors. In this study, H~2~O~2~ appeared to stimulate the translocation of both c-Jun and c-Fos, the major downstream components of MAPKs and was upregulated by JNK and ERK phosphorylation (Fig. [5](#F5){ref-type="fig"}A). To further explore the possible inhibitory mechanisms of DMA on H~2~O~2~-mediated MMP-7 transcriptional regulation, we examined the effects of DMA and MAPK inhibitors on AP-1 activation using the luciferase reporter gene assay. DMA, SP600125 (JNK1/2 inhibitor), or PD98059 (ERK1/2 inhibitor) interfered with the DNA binding of AP-1 accompanied with down regulation of JNK/c-Jun and ERK/c-Fos expression (Fig. [5](#F5){ref-type="fig"}B). To further clarify the involvement of JNK and ERK signaling in H~2~O~2~-induced MMP-7 expression, SW620 cells were cultured with H~2~O~2~ in the absence or presence of DMA (100 μM), SP600125 (50 μM), PD98059 (50 μM), or SB203580 (10 μM) respectively. DMA, SP600125 (JNK1/2 inhibitor), and PD98059 (ERK1/2 inhibitor) but not SB203580 (p38 MAPK inhibitor) significantly downregulated MMP-7 mRNA expression (Fig. [5](#F5){ref-type="fig"}C). These data indicate that stimulation of MMP-7 expression by H~2~O~2~ requires activation of JNK/c-Jun and ERK/c-Fos, but not p38 MAPK via the AP-1 signaling pathway. Based on these findings, we deduced that DMA suppressed H~2~O~2~-induced MMP-7 expression and cell invasion by inhibiting AP-1-mediated gene transcription via the JNK/c-Jun and ERK/c-Fos pathways (Fig. [6](#F6){ref-type="fig"}).

Discussion
==========

Surgery of primary tumors provides the best prognosis for patients with CRC. Unfortunately, a significant portion of CRC patients will develop metastases, even after successful resection of the primary tumor. The effect of surgery on metastasis may be attributed to a number of risk factors, suggesting that surgical treatment induces inflammation associated with severe oxidative stress. ROS have contributed to various aspects of malignant tumors, including carcinogenesis, aberrant proliferation, angiogenesis, and metastasis, all of which serve as second messengers in the gene regulatory and signal transduction pathways within cells [@B23].

In relation to the stimulating effects of low H~2~O~2~ concentration, early studies have demonstrated that low-dose H~2~O~2~ induced cell proliferation possibly via various elevated factors [@B2], [@B4], [@B26]-[@B29]. Here, we show that exposure of SW620 cells to lower levels of H~2~O~2~ (1 μM) actually stimulated statistically significant proliferation. Nevertheless, there were no significant differences among 2.5-5 μM H~2~O~2~ concentrations for 24-h treatment (Fig. [1](#F1){ref-type="fig"}B).

Interestingly, DMA pretreatment effectively attenuated H~2~O~2~-induced cell invasion through Matrigel-coated Boyden chambers (Fig. [2](#F2){ref-type="fig"}). To examine whether MMP-7 was involved in response to exogenous H~2~O~2~-induced oxidative stress in SW620 cells, the expression profiles of MMP-7 mRNA were confirmed by RT-PCR. Although time-dependent elevation of MMP-7 mRNA following H~2~O~2~ administration had been observed, it could be effectively suppressed by DMA pretreatment (Figs. [3](#F3){ref-type="fig"}A & [3](#F3){ref-type="fig"}B). In clinical reports, MMP-7 expression has been considered one of the major mechanisms leading to the poor survival rate of CRC patients [@B9]-[@B10]. Moreover, evidence is emerging that members of the MMP family including MMP-2, -7, -9, and -13 can serve not only as potential prognostic biomarkers, but also as indicators of tumor recurrence, metastatic spread, and response to primary and adjuvant therapy for CRC [@B30].

Expression of MMPs in tumors has been shown to be involved in activation of numerous MAPKs that are mediated in an autocrine or paracrine manner by growth factors, cytokines, or endogenous oxidative stress factors secreted by tumor-infiltrating inflammatory cells, stromal cells, or the tumor itself [@B31]-[@B32]. Our results provide evidence that exogenous H~2~O~2~ exposure could remarkably contribute to increased phosphorylation of all 3 MAPKs (JNK, ERK, and p38 MAPK), but have failed to find during DMA intervention (Figs. [4](#F4){ref-type="fig"}A-C). Furthermore, DMA significantly inhibited H~2~O~2~-mediated MMP-7 expression that might be associated with attenuation of JNK and ERK signaling axes (Fig. [4](#F4){ref-type="fig"}D). In addition to the exogenous H~2~O~2~ in our results, induction of MMP-7 activation has been observed in fibroblast growth factor-1 (FGF-1) [@B33], hepatocyte growth factor/scatter factor (HGF/SF) [@B34], vascular endothelial growth factor (VEGF) and interlukin-8 (IL-8) [@B35]. In addition, environmental insults such as ultraviolet B (UVB) radiation [@B36], cigarette smoke exposure [@B37], dietary components [@B38], and microorganism infection [@B39] contribute to the generation of free radicals and ROS that stimulate the inflammatory process and trigger MMP-7 expression.

Tumor cells, stromal cells, and infiltrating immune cells all contribute to benefit the tumor microenvironment via direct or indirect mediation. In the tumor milieu, infiltrating inflammatory cells receive ample activation signals and release abundant ROS to promote tumor progression. Among the ROS, H~2~O~2~ has a relatively long biological half-life and is able to diffuse across the cell membrane to modulate many downstream signaling molecules, such as transcription factors and protein kinases [@B23]. It has been proposed that invasion-associated MMPs are regulated by AP-1 to regulate a program of gene expression that induces invasion in tumor cells [@B25]. In our results, we attempted to clarify the potential molecular mechanisms responsible for the H~2~O~2~-induced activation of MMP-7. We suggested that H~2~O~2~-induced MMP-7 activation was AP-1-dependent through parallel signaling pathways that may involve the JNK/c-Jun and ERK/c-Fos signaling cascades (Fig. [5](#F5){ref-type="fig"}). Based on previous evidence of the radical scavenging activity of DMA [@B17], we described a hypothetical schematic model to demonstrate the potential role of DMA in H~2~O~2~-induced activation of MMP-7 and cancer invasion (Fig. [6](#F6){ref-type="fig"}). Further studies should be conducted in the future to demonstrate whether the effects of DMA on MMP-7 expression and cell invasion were mediated by its inhibitory role in the JNK and ERK signaling pathways. JNK/c-Jun and ERK/c-Fos activation should also be addressed to explain whether the AP-1 binding site of c-Jun and c-Fos in pAP1-luc is identical to that in the MMP-7 promoter.

Various adjuvant therapeutic strategies to prevent tumor recurrence after surgery have been explored and offer promising means of improving patients\' outcome [@B40]-[@B43]. Dietary chemoprevention has recently received attention for CRC prevention. Use of natural dietary compounds has received extensive thought for cancer prevention [@B44]. Moreover, functional *Monascus*-fermented products containing several essential secondary metabolites with various biological activities have been described in our previous studies [@B45]-[@B50]. In this study, we found that exogenous H~2~O~2~ can stimulate cell invasion activity and that DMA pretreatment can reverse the malignant phenotype of cancer cells. These results suggest that DMA plays not only a free radical scavenger but also an essential role in preventing cancer metastasis.
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![Effects of DMA or H~2~O~2~ on SW620 cell viability. A, chemical structure of DMA isolated from *M. purpureus* NTU 568. B, SW620 cells were treated with DMA (●) or H~2~O~2~ (○) at various doses for 24 h. The results represent dose-dependent effects of H~2~O~2~ but not DMA on SW620 cells. C, time-dependent decline of cell viability after H~2~O~2~ (10 μM) treatment. In each experiment, cell viability in vehicle-treated control was designated as 100%. Data represent the mean ± SD of reduction in cell viability of three independent experiments.](ijbsv07p0869g01){#F1}

![Preventive effect of DMA on exogenous H~2~O~2~-stimulated invasion promotion of SW620 cells. A, visualization of dose-dependent increases SW620 cell invasion by H~2~O~2~ treatment. Equal numbers of cells were added to the upper wells of Matrigel-coated chambers in serum-free L-15 medium with various doses of H~2~O~2~. After incubation for 24 h, remaining cells in the upper chambers were removed by scrubbing with cotton swabs, and cells that invaded the lower chambers were fixed and stained with 0.5% crystal violet. B, DMA suppresses H~2~O~2~-induced Matrigel invasion of metastatic SW620 cancer cells. Cells were seeded atop chamber membranes in the presence or absence of 5 μM of H~2~O~2~ (- or + 100 μM DMA, respectively) with 10% FBS in the bottom well as the chemoattractant. After 24 h, the invaded cells were fixed, stained, and counted microscopically. The present data use of 100 μM DMA combination with H~2~O~2~ are significantly different (\*p \< 0.05, Student\'s *t* test) from date of H~2~O~2~-treatment alone. C, MMP-7 neutralizing antibody suppresses H~2~O~2~-induced Matrigel invasion of metastatic SW620 cancer cells. Cells were pretreated with H~2~O~2~ (5 μM), MMP-7 neutralizing antibody (10 μg/mL), or IgG and placed in the upper chamber coated with Matrigel. After 24-h culture, the invasive cells were fixed and counted. Each pretreatment was plated in triplicate in each experiment. \*p \< 0.05 was considered statistically significant.](ijbsv07p0869g02){#F2}

![Effect of H~2~O~2~ on MMP-7 activation and expression in SW620 cells. A, H~2~O~2~ induced MMP-7 mRNA expression in a time-dependent manner. RT-PCR analysis demonstrated that non-lethal H~2~O~2~ levels (5 μM) immediately induced MMP-7 mRNA expression that plateaued at 4 h. TPA was used as a positive control for DMA. B, H~2~O~2~-induced dose-dependent increase of MMP-7 mRNA expression. SW620 cells were treated with H~2~O~2~ at the indicated doses for 4 h. RT-PCR products of MMP-7 after H~2~O~2~ treatment increased in a dose-dependent manner. Cells were pretreated with DMA (100 μM) for 30 min followed by incubation for additional 4 h in the absence or presence of H~2~O~2~ (5 μM). The densitometry graph shows that DMA (100 μM) pretreatment induced a significant reduction in MMP-7 mRNA expression compared to that of H~2~O~2~ (5 μM) treatment only (\*p \< 0.05). C, Western blot analyses showed that H~2~O~2~ (5 μM) induced MMP-7 secretion in a time-dependent manner. Whole cell lysates were immunoblotted with β-actin antibody for the normalization of cell numbers. D, casein zymogram showing the presence of MMP-7 in SW620 cells after H~2~O~2~ (5 μM) treatment for the indicated time. Areas of casein substrate cleared by MMP-7 were seen in H~2~O~2~ (5 μM)-treated samples but declined in the presence of DMA (100 μM). The casein zymographic analysis plots were performed using lytic bands normalized for protein concentration. DMA pretreatment (open bar) in the presence of H~2~O~2~ (5 μM) for 48 h significantly suppressed the caseinolytic activity compared to H~2~O~2~ (5 μM) treatment only (\*p \< 0.05). All experiments from three independent experiments are plotted. Columns represent the mean ± SD.](ijbsv07p0869g03){#F3}

![Analysis of the different MAPK pathways activated by H~2~O~2~ in SW620 cells. SW620 cells were cultured in serum-free L-15 medium for 24 h to synchronize the cells and to make them quiescent prior to treatment with SP600125 (50 μM; JNK1/2 phosphorylation inhibitor), PD98059 (50 μM; ERK1/2 phosphorylation inhibitor), or SB203580 (10 μM; p38 MAPK phosphorylation inhibitor) for 30 min prior to the addition of H~2~O~2~ (5 μM) for 1 h. Cell lysates were prepared and immunoblotted with the antibodies indicated in the panel. A, the levels of phospho-JNK1/2 were evaluated by H~2~O~2~ stimulation and suppressed by SP600125 or DMA (100 μM) pretreatment. B, the levels of phospho-ERK1/2 were evaluated by H~2~O~2~ stimulation and suppressed by PD98059 or DMA (100 μM) pretreatment. C, the level of phospho-p38 MAPK was evaluated by H~2~O~2~ stimulation and suppressed by SB203580 or DMA (100 μM) pretreatment. Ratios of bands with phosphospecific versus non-phosphospecific MAPK antibodies were determined, and quantitated by densitometry using the ImageJ program (NIH). Means ± SD are given. D, H~2~O~2~-enhanced MMP-7 protein expression was associated with increased JNK and ERK signaling in SW620 cells. Pretreatment with DMA (100 μM), SP600125 (50 μM), or PD98059 (50 μM) for 30 min prior to H~2~O~2~ (5 μM) induction for 8 h in SW620 cells significantly declined the expression of MMP-7 compared with H~2~O~2~-only treatment (\*p \< 0.05). However, the level of MMP-7 protein was only slightly decreased with no significant difference effect in the presence of SB203580 (10 μM) after H~2~O~2~-induced MAPK stimulation. The bars in the lower panel denote means ± S.D. of three experiments for each condition determined from densitometry relative to β-actin.](ijbsv07p0869g04){#F4}

![Regulation of MMP-7 transcription is dependent on JNK/c-Jun and ERK/c-Fos activities in H~2~O~2~-treated SW620 cells. A, effects of DMA and MAPK inhibitors on H~2~O~2~-induced c-Jun and c-Fos translocation. Nucleoprotein was isolated from SW620 cells treated with DMA (100 μM), SP600125 (50 μM), or PD98059 (50 μM) for 30 min prior to H~2~O~2~ (5 μM) induction for 4 h. Afterward, Western blotting analysis was performed using specific antibodies against c-Jun and c-Fos. Expression of lamin B1 was examined in parallel to confirm that equal amounts of nucleoprotein were being analyzed for each condition. The right upper panel showed that the JNK inhibitor SP600125 and DMA effectively inhibited H~2~O~2~-induced c-Jun translocation. The right lower panel showed that the ERK inhibitor PD98059 and DMA effectively inhibited H~2~O~2~-induced c-Fos translocation. B, DMA suppressed H~2~O~2~-induced AP-1 transcriptional activity. AP-1 activation was induced by H~2~O~2~ treatment via the JNK/cJun and ERK/c-Fos signaling pathways. SW620 cells were transiently transfected with AP-1 luciferase reporter (pAP1-luc) and pRL-TK reference vector for 24 h and were co-cultured with DMA or MAPK inhibitors in the absence (□) or presence (■) of H~2~O~2~(5 μM). Relative luciferase activities were measured by calculating the light emitted and were normalized by coexpression of pRL-TK Renilla luciferase (ratio multiplied by an arbitrary factor to set the control of H~2~O~2~ induction only to 100). The relative luciferase activities are presented as means ± SD. C, H~2~O~2~-stimulated MMP-7 transcription depends on both JNK and ERK signaling activation. Pretreatment with DMA (100 μM), SP600125 (50 μM), or PD98059 (50 μM) for 30 min prior to H~2~O~2~ (5 μM) induction for 4 h in SW620 cells significantly reduced the expression of MMP-7 mRNA compared with H~2~O~2~-only treatment (\*p \< 0.05). The bars in the lower panel denote means ± SD of three experiments for each condition determined from densitometry relative to GAPDH mRNA.](ijbsv07p0869g05){#F5}

![Schematic model of the proposed signal pathways inhibition of cancer cell invasion by DMA. Exogenous H~2~O~2~ triggers JNK1/2 and ERK1/2 activation, thereby inducing the expression of c-Jun and c-Fos, respectively. The c-Jun and c-Fos proteins cooperatively bind to the AP-1 binding site and promote *MMP-7* gene transcription. DMA acts as an inhibitor of the JNK1/2 and ERK1/2 signaling pathways, suppressing H~2~O~2~-induced MAPK activation and MMP-7 expression.](ijbsv07p0869g06){#F6}
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